Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.3.0.814
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash $ 9,690 $ 15,470
Receivables 3,898 3,968
Prepaid expenses and other current assets 262 145
Total current assets 13,850 19,583
Property and equipment, net 1,059 1,268
Total assets 14,909 20,851
Current liabilities:    
Accounts payable 4,038 4,408
Accrued clinical trials expenses 206 254
Other accrued liabilities 350 329
Deferred contract revenue 0 1,671
Total current liabilities 4,594 6,662
Warrant liabilities 1,398 5,578
Total liabilities $ 5,992 $ 12,240
Commitments and contingencies
Stockholders' equity:    
Common stock, at amounts paid-in $ 297,828 $ 289,196
Additional paid-in capital 22,894 22,235
Accumulated deficit (311,805) (302,820)
Total stockholders' equity 8,917 8,611
Total liabilities and stockholders’ equity $ 14,909 $ 20,851